XORTX names Bruce Rowlands as chairman

XORTX-Therapeutics.jpg

XORTX Therapeutics (CSE:XRX) appointed Bruce Rowlands, a director, as chairman of the board.

Mr. Rowlands has extensive experience in the life sciences industry in Canada through his long association with Lorus Therapeutics, where he acted as a
consultant, banker and senior executive during its early drug development years, and as a VP and director of investment banker, Dominick & Dominick Securities.

In a statement, Dr. Allen Davidoff, founder and CEO of XORTX, said Mr. Rowlands has been an excellent director and supporter of XORTX for several years and expanding his role with XORTX is a natural transition. 

“This expanded role will permit him to bring his broad capital markets and extensive pharmaceutical industry talents to the benefit of the XORTX,” he added. 

Sydney Stewart